Cyclophosphamide, a nitrogen mustard alkylating prodrug, requires metabolic activation and undergoes CYP2B6/CYP2C9 mediated oxidation to induce DNA damage and cell death in target cancer cells [34,35]. The gene discussed is CYP2C9; the disease is cancer.